ANI Pharmaceuticals | ANIP - Assets

Stock Price
79.61
Daily Change
-0.27 -0.34%
Monthly
1.21%
Yearly
35.88%
Q1 Forecast
79.33

ANI Pharmaceuticals reported $1.41B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.9B 3.28B Sep/2025
ANI Pharmaceuticals USD 1.41B 65.15M Sep/2025
Aurora Cannabis CAD 756.86M 80.98M Sep/2025
Canopy Growth CAD 1.07B 165.17M Sep/2025
Eli Lilly USD 114.94B 14.01B Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Novartis USD 107.29B 2.89B Sep/2025
Perrigo USD 10.08B 10.1M Sep/2025
Sun Pharmaceuticals INR 1.04T 116.06B Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025